Sitagliptin Tartrate

酒石酸西格列汀

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSitagliptin Tartrate
Drug Alias Name西格列汀酒石酸盐Sitagliptin Heumann 25 mg Filmtabletten
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetic NephropathiesParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2020/12/14
Country/TerritoryNetherlandsEgyptEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHeumann Pharma GmbH & Co Generica KG
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterAin Shams UniversityHeumann Pharma GmbH & Co Generica KG
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Diabetic NephropathiesParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA10BH01
Related LinksWikipediaKEGG